Two-Stage Efficiency Measurement and Technological Heterogeneity: Evidence from the Biotechnological Industry in Taiwan

This paper explores the operational and market efficiencies of various biotechnological company formats in Taiwan during the period 2006 to 2008 by adopting the two-stage directional distance function and the meta-frontier concept. It conducts an efficiency assessment by taking into account a five-year time lag between R&D investments and actually obtaining a patent in order to better reflect the actual business operating process and thus more accurately gauge the efficiency of business operations in biotechnological companies. The empirical results show that non-listed companies registered better operational efficiency in the first stage, whereas their market efficiency in the second stage is inferior to that of listed companies when the meta-technology set is used as a basis. The average operation gap ratio and market gap ratio of non-listed companies exceeded those of listed firms, indicating that the technological heterogeneity (i.e., the gap) of non-listed companies is smaller than that of listed ones.

[1]  H. Saranga,et al.  Multiple objective data envelopment analysis as applied to the Indian Pharmaceutical Industry , 2007, J. Oper. Res. Soc..

[2]  Joe Zhu,et al.  Multi-factor performance measure model with an application to Fortune 500 companies , 2000, Eur. J. Oper. Res..

[3]  Joe Zhu,et al.  A bargaining game model for measuring performance of two-stage network structures , 2011, Eur. J. Oper. Res..

[4]  Hariolf Grupp,et al.  External Effects as a Microeconomic Determinant of Innovation Efficiency , 1997 .

[5]  Rolf Färe,et al.  Productivity and Undesirable Outputs: A Directional Distance Function Approach , 1995 .

[6]  L. Seiford,et al.  Profitability and Marketability of the Top 55 U.S. Commercial Banks , 1999 .

[7]  Haritha Saranga,et al.  Determinants of operational efficiencies in the Indian pharmaceutical industry , 2009, Int. Trans. Oper. Res..

[8]  Theodore Sougiannis The Accounting Based Valuation of Corporate R&D , 1994 .

[9]  B. Lev,et al.  The capitalization, amortization, and value-relevance of R&D , 1996 .

[10]  Sten Thore,et al.  Fundamental analysis of stocks by two-stage DEA , 2004 .

[11]  Ming-Miin Yu,et al.  Efficiency and effectiveness of service business: evidence from international tourist hotels in Taiwan. , 2009 .

[12]  Shiuh-Nan Hwang,et al.  Measuring Managerial Efficiency in Non-Life Insurance Companies: An Application of Two-Stage Data Envelopment Analys , 2006 .

[13]  Naoki Murakami,et al.  Private and quasi-social rates of return on pharmaceutical R&D in Japan , 1992 .

[14]  Wen-Min Lu,et al.  Does Size Matter? Finding the Profitability and Marketability Benchmark of Financial Holding Companies , 2006, Asia Pac. J. Oper. Res..

[15]  Cheng-Jen Huang,et al.  Exploration for the Relationship between Innovation, IT and Performance , 2005 .

[16]  Chiang Kao,et al.  Efficiency decomposition in two-stage data envelopment analysis: An application to non-life insurance companies in Taiwan , 2008, Eur. J. Oper. Res..

[17]  Cherng G. Ding,et al.  Efficiency and productivity of Taiwan's biotech industry , 2005 .

[18]  梁馨科,et al.  Effects of Integrative Strategies on the Production Efficiency of Biotech Firms: A Data Envelopment Analysis , 2008 .

[19]  Wen-Min Lu,et al.  An integrated performance evaluation of financial holding companies in Taiwan , 2009, Eur. J. Oper. Res..

[20]  Walter G. Park,et al.  INTERNATIONAL R&D SPILLOVERS AND OECD ECONOMIC GROWTH , 1995 .

[21]  Eduardo González,et al.  Sources of productivity growth in the Spanish pharmaceutical industry (1994-2000) , 2004 .

[22]  G. Battese,et al.  Metafrontier frameworks for the study of firm-level efficiencies and technology ratios , 2008 .

[23]  M. Flor,et al.  Identification of innovating firms through technological innovation indicators: an application to the Spanish ceramic tile industry , 2004 .

[24]  F. M. Scherer,et al.  The lag structure of returns to research and development , 1982 .

[25]  Herbert F. Lewis,et al.  Two-Stage DEA: An Application to Major League Baseball , 2003 .

[26]  Ryuhei Wakasugi,et al.  R&D, Firm Size and Innovation Outputs: Are Japanese Firms Efficient in Product Development? , 1997 .

[27]  A. Hashimoto,et al.  Measuring the change in R&D efficiency of the Japanese pharmaceutical industry , 2008 .

[28]  Xueming Luo Evaluating the profitability and marketability efficiency of large banks: An application of data envelopment analysis , 2003 .

[29]  Sharmistha Bagchi-Sen,et al.  An analysis of firm-level innovation strategies in the US biotechnology industry , 2007 .

[30]  Paul W. Wilson,et al.  Detecting influential observations in data envelopment analysis , 1995 .